Diagnostic accuracy assessment of molecular prediction model for the risk of NAFLD based on MRI-PDFF diagnosed Chinese Han population
Background Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study...
Saved in:
Published in | BMC gastroenterology Vol. 21; no. 1; pp. 88 - 7 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
25.02.2021
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1471-230X 1471-230X |
DOI | 10.1186/s12876-021-01675-y |
Cover
Abstract | Background
Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population.
Patients and methods
MRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0.
Results
A total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions.
Conclusions
The molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD. |
---|---|
AbstractList | Background
Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population.
Patients and methods
MRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0.
Results
A total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions.
Conclusions
The molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD. Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population. MRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0. A total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions. The molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD. Background Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population. Patients and methods MRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0. Results A total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions. Conclusions The molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD. Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population.BACKGROUNDSeveral molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population.MRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0.PATIENTS AND METHODSMRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0.A total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions.RESULTSA total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions.The molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD.CONCLUSIONSThe molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD. Abstract Background Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population. Patients and methods MRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0. Results A total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions. Conclusions The molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD. Background Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population. Patients and methods MRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0. Results A total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions. Conclusions The molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD. Keywords: Non-alcoholic fatty liver disease, MRI-PDFF, Molecular prediction model Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population. MRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0. A total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions. The molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD. |
ArticleNumber | 88 |
Audience | Academic |
Author | Zhao, Zhenzhen Yu, Wanjiang Xu, Zhipeng Lv, Kuirong Zhu, Yueli Zhang, Qing Xin, Yongning Liu, Shousheng |
Author_xml | – sequence: 1 givenname: Qing surname: Zhang fullname: Zhang, Qing organization: Department of Radiology, Qingdao Municipal Hospital – sequence: 2 givenname: Yueli surname: Zhu fullname: Zhu, Yueli organization: Department of Radiology, Qingdao Municipal Hospital – sequence: 3 givenname: Wanjiang surname: Yu fullname: Yu, Wanjiang organization: Department of Radiology, Qingdao Municipal Hospital – sequence: 4 givenname: Zhipeng surname: Xu fullname: Xu, Zhipeng organization: Department of Radiology, Qingdao Municipal Hospital – sequence: 5 givenname: Zhenzhen surname: Zhao fullname: Zhao, Zhenzhen organization: Clinical Research Center, Qingdao Municipal Hospital – sequence: 6 givenname: Shousheng surname: Liu fullname: Liu, Shousheng organization: Clinical Research Center, Qingdao Municipal Hospital – sequence: 7 givenname: Yongning surname: Xin fullname: Xin, Yongning email: xinyongning@163.com organization: Department of Infectious Disease, Qingdao Municipal Hospital – sequence: 8 givenname: Kuirong surname: Lv fullname: Lv, Kuirong email: lvkr5169@163.com organization: Department of Radiology, Qingdao Municipal Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33632126$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ksuO0zAUhiM0iLnAC7BAltiwyeBbHGeDNGopU6lchEBiZzm207okdrETpD4A743TDDPTERplkej4_7_jc_KfZyfOO5NlLxG8RIiztxFhXrIcYpRDxMoi3z_JzhAtUY4J_HFy7_s0O49xCyEqOSbPslNCGMEIs7Psz9zKtfOxtwpIpYYg1R7IGE2MnXE98A3ofGvU0MoAdsFoq3rrXSpq04LGB9BvDAg2_hyln64WqzmoZTQaJNHHr8v8y3yxAHpqkqqzjXUmGnAtHdj5XcKOuOfZ00a20by4eV9k3xfvv82u89XnD8vZ1SpXDJZ9XjdcU1lKBEnDFEeQq4pySBWGFSmaknCNCCsNRDQdNqimBFW4ILwhqCykIhfZcuJqL7diF2wnw154acWh4MNayJBW0RqBaqULzqta6prWvJIE00LxtNFCIwpH1ruJtRvqzmiVthVkewQ9PnF2I9b-tygryBklCfDmBhD8r8HEXnQ2KtO20hk_RIFpRUn6saxM0tcPpFs_BJdWJXABcSIWiN2p1jINYF3jU181QsUVKwhjpIIj6_I_qvRo01mVEtbYVD8yvLo_6O2E_0KUBHgSqOBjDKa5lSAoxqSKKakiJVUckir2ycQfmJTtD2FI17Ht41YyWWPq49Ym3G3jEddf7jn7hg |
CitedBy_id | crossref_primary_10_3389_fcvm_2022_938902 crossref_primary_10_5527_wjn_v13_i3_97214 crossref_primary_10_1159_000530531 crossref_primary_10_3390_diagnostics13213316 crossref_primary_10_1186_s12944_023_01966_1 crossref_primary_10_1007_s13105_023_00991_z crossref_primary_10_1186_s12876_021_02088_7 crossref_primary_10_1111_apt_17914 |
Cites_doi | 10.1053/j.gastro.2015.11.048 10.1002/hep.23345 10.3748/wjg.v19.i40.6735 10.1007/s00134-019-05594-1 10.1016/j.cgh.2018.05.058 10.1016/j.diabet.2016.11.006 10.1016/j.phrs.2018.07.014 10.1111/liv.13653 10.1111/jgh.12557 10.1148/radiol.14140754 10.1111/liv.13413 10.1136/bmj.2.5402.177 10.1002/hep.29797 10.1002/jmri.24452 10.1002/hep.30251 10.3390/nu11030705 10.1038/s41591-018-0104-9 10.1002/hep.30350 10.1002/hep.21346 10.1007/s00330-019-06072-4 10.1053/j.gastro.2017.06.005 10.15252/msb.20188793 10.1186/1471-230X-6-33 10.1002/mrm.26228 10.1002/hep.26455 10.1038/nrgastro.2017.109 10.1053/j.gastro.2009.06.005 10.1016/j.jhep.2017.11.013 10.1136/gutjnl-2012-302789 10.1002/hep.29596 10.1148/radiol.10100659 10.1001/jama.2015.5370 10.1002/dmrr.3158 10.1002/jmri.24321 10.1001/jamapediatrics.2014.2702 |
ContentType | Journal Article |
Copyright | The Author(s) 2021 COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2021 – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7QR 7T5 7X7 7XB 88E 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH H94 K9. M0S M1P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12876-021-01675-y |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One ProQuest Central Engineering Research Database ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Biotechnology and BioEngineering Abstracts Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-230X |
EndPage | 7 |
ExternalDocumentID | oai_doaj_org_article_1bcd5889badb4b89a3245c84715d140c PMC7908643 A653663907 33632126 10_1186_s12876_021_01675_y |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: National Natural Science Foundation of China grantid: 31770837 funderid: http://dx.doi.org/10.13039/501100001809 – fundername: National Natural Science Foundation of China grantid: 31770837 – fundername: ; grantid: 31770837 |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 3V. 7QP 7QR 7T5 7XB 8FD 8FK AZQEC DWQXO FR3 H94 K9. P64 PKEHL PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c607t-bf8d4a7a103f6c8108c94804c20935f738d1367e014810f1b43192538f3175ac3 |
IEDL.DBID | M48 |
ISSN | 1471-230X |
IngestDate | Wed Aug 27 01:31:09 EDT 2025 Thu Aug 21 17:29:17 EDT 2025 Thu Sep 04 19:44:11 EDT 2025 Fri Jul 25 21:12:16 EDT 2025 Tue Jun 17 21:27:20 EDT 2025 Tue Jun 10 20:49:25 EDT 2025 Thu Apr 03 06:53:04 EDT 2025 Tue Jul 01 04:12:05 EDT 2025 Thu Apr 24 23:12:40 EDT 2025 Sat Sep 06 07:35:46 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Non-alcoholic fatty liver disease Molecular prediction model MRI-PDFF |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c607t-bf8d4a7a103f6c8108c94804c20935f738d1367e014810f1b43192538f3175ac3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://doi.org/10.1186/s12876-021-01675-y |
PMID | 33632126 |
PQID | 2502790516 |
PQPubID | 44673 |
PageCount | 7 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_1bcd5889badb4b89a3245c84715d140c pubmedcentral_primary_oai_pubmedcentral_nih_gov_7908643 proquest_miscellaneous_2494301667 proquest_journals_2502790516 gale_infotracmisc_A653663907 gale_infotracacademiconefile_A653663907 pubmed_primary_33632126 crossref_primary_10_1186_s12876_021_01675_y crossref_citationtrail_10_1186_s12876_021_01675_y springer_journals_10_1186_s12876_021_01675_y |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-02-25 |
PublicationDateYYYYMMDD | 2021-02-25 |
PublicationDate_xml | – month: 02 year: 2021 text: 2021-02-25 day: 25 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | BMC gastroenterology |
PublicationTitleAbbrev | BMC Gastroenterol |
PublicationTitleAlternate | BMC Gastroenterol |
PublicationYear | 2021 |
Publisher | BioMed Central BioMed Central Ltd BMC |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
References | M Schetz (1675_CR33) 2019; 45 P Bedossa (1675_CR7) 2018; 38 Z Younossi (1675_CR2) 2018; 15 V Nobili (1675_CR27) 2015; 169 G Bedogni (1675_CR17) 2006; 6 S Saokaew (1675_CR32) 2017; 37 Z Younossi (1675_CR1) 2019; 69 S Fiorucci (1675_CR3) 2018; 134 M Noureddin (1675_CR12) 2013; 58 S Bonekamp (1675_CR8) 2014; 39 G Tarantino (1675_CR28) 2013; 19 1675_CR14 A Kotronen (1675_CR18) 2009; 137 I Croci (1675_CR34) 2013; 62 1675_CR13 1675_CR35 A Tang (1675_CR25) 2015; 274 MS Middleton (1675_CR29) 2017; 153 E Vilar-Gomez (1675_CR31) 2018; 68 Y Ma (1675_CR22) 2019; 69 WK Chan (1675_CR10) 2014; 29 MS Middleton (1675_CR15) 2018; 67 L Niu (1675_CR19) 2019; 15 ME Rinella (1675_CR5) 2015; 313 RB Merriman (1675_CR6) 2006; 44 J Gu (1675_CR16) 2019; 29 1675_CR21 C Caussy (1675_CR11) 2018; 68 1675_CR20 K Kantartzis (1675_CR30) 2017; 43 1675_CR9 1675_CR26 1675_CR23 1675_CR24 SL Friedman (1675_CR4) 2018; 24 |
References_xml | – ident: 1675_CR14 doi: 10.1053/j.gastro.2015.11.048 – ident: 1675_CR9 doi: 10.1002/hep.23345 – volume: 19 start-page: 6735 issue: 40 year: 2013 ident: 1675_CR28 publication-title: World J Gastroenterol doi: 10.3748/wjg.v19.i40.6735 – volume: 45 start-page: 757 issue: 6 year: 2019 ident: 1675_CR33 publication-title: Intensive Care Med doi: 10.1007/s00134-019-05594-1 – ident: 1675_CR21 doi: 10.1016/j.cgh.2018.05.058 – volume: 43 start-page: 229 issue: 3 year: 2017 ident: 1675_CR30 publication-title: Diabetes Metab doi: 10.1016/j.diabet.2016.11.006 – volume: 134 start-page: 289 year: 2018 ident: 1675_CR3 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2018.07.014 – volume: 38 start-page: 64 issue: Suppl 1 year: 2018 ident: 1675_CR7 publication-title: Liver Int doi: 10.1111/liv.13653 – volume: 29 start-page: 1470 issue: 7 year: 2014 ident: 1675_CR10 publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.12557 – volume: 274 start-page: 416 issue: 2 year: 2015 ident: 1675_CR25 publication-title: Radiology doi: 10.1148/radiol.14140754 – volume: 37 start-page: 1535 issue: 10 year: 2017 ident: 1675_CR32 publication-title: Liver Int doi: 10.1111/liv.13413 – ident: 1675_CR23 doi: 10.1136/bmj.2.5402.177 – volume: 68 start-page: 763 issue: 2 year: 2018 ident: 1675_CR11 publication-title: Hepatology doi: 10.1002/hep.29797 – ident: 1675_CR24 doi: 10.1002/jmri.24452 – volume: 69 start-page: 2672 issue: 6 year: 2019 ident: 1675_CR1 publication-title: Hepatology doi: 10.1002/hep.30251 – ident: 1675_CR20 doi: 10.3390/nu11030705 – volume: 24 start-page: 908 issue: 7 year: 2018 ident: 1675_CR4 publication-title: Nat Med doi: 10.1038/s41591-018-0104-9 – volume: 69 start-page: 1504 issue: 4 year: 2019 ident: 1675_CR22 publication-title: Hepatology doi: 10.1002/hep.30350 – volume: 44 start-page: 874 issue: 4 year: 2006 ident: 1675_CR6 publication-title: Hepatology doi: 10.1002/hep.21346 – volume: 29 start-page: 3564 issue: 7 year: 2019 ident: 1675_CR16 publication-title: Eur Radiol doi: 10.1007/s00330-019-06072-4 – volume: 153 start-page: 753 issue: 3 year: 2017 ident: 1675_CR29 publication-title: Gastroenterology doi: 10.1053/j.gastro.2017.06.005 – volume: 15 start-page: e8793 issue: 3 year: 2019 ident: 1675_CR19 publication-title: Molecular systems biology doi: 10.15252/msb.20188793 – volume: 6 start-page: 33 year: 2006 ident: 1675_CR17 publication-title: BMC Gastroenterol doi: 10.1186/1471-230X-6-33 – ident: 1675_CR35 doi: 10.1002/mrm.26228 – volume: 58 start-page: 1930 issue: 6 year: 2013 ident: 1675_CR12 publication-title: Hepatology doi: 10.1002/hep.26455 – volume: 15 start-page: 11 issue: 1 year: 2018 ident: 1675_CR2 publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2017.109 – volume: 137 start-page: 865 issue: 3 year: 2009 ident: 1675_CR18 publication-title: Gastroenterology doi: 10.1053/j.gastro.2009.06.005 – volume: 68 start-page: 305 issue: 2 year: 2018 ident: 1675_CR31 publication-title: J Hepatol doi: 10.1016/j.jhep.2017.11.013 – volume: 62 start-page: 1625 issue: 11 year: 2013 ident: 1675_CR34 publication-title: Gut doi: 10.1136/gutjnl-2012-302789 – volume: 67 start-page: 858 issue: 3 year: 2018 ident: 1675_CR15 publication-title: Hepatology doi: 10.1002/hep.29596 – ident: 1675_CR13 doi: 10.1148/radiol.10100659 – volume: 313 start-page: 2263 issue: 22 year: 2015 ident: 1675_CR5 publication-title: JAMA doi: 10.1001/jama.2015.5370 – ident: 1675_CR26 doi: 10.1002/dmrr.3158 – volume: 39 start-page: 1525 issue: 6 year: 2014 ident: 1675_CR8 publication-title: J Magn Reson Imaging doi: 10.1002/jmri.24321 – volume: 169 start-page: 170 issue: 2 year: 2015 ident: 1675_CR27 publication-title: JAMA Pediatr doi: 10.1001/jamapediatrics.2014.2702 |
SSID | ssj0017823 |
Score | 2.3125217 |
Snippet | Background
Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the... Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these... Background Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the... Abstract Background Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 88 |
SubjectTerms | Accuracy Age Biopsy Blood pressure Body mass index China Diabetes Diagnosis Evaluation Fatty liver Gastroenterology Hepatitis Hepatobiliary and pancreatic disorders Hepatology Humans Internal Medicine Liver - diagnostic imaging Liver diseases Magnetic Resonance Imaging Medicine Medicine & Public Health Metabolic syndrome Molecular diagnostic techniques Molecular modelling Molecular prediction model MRI-PDFF Non-alcoholic fatty liver disease Non-alcoholic Fatty Liver Disease - diagnostic imaging Prediction models Research Article ROC Curve Software Statistical analysis Steatosis Ultrasonic imaging |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEA6yB_Eivm1dJYLgQcP2I52kj6NjM4qziLiwt5BXo6A9wzwO8wP2f29V-uH2inrx2qlMJ6lK5atJ9VeEvBQQcSnpORNgHIyLwFllhGO5Mg7p2IOMN6bLU7E44x_Py_Mrpb4wJ6yjB-4W7iSzzpdKVdZ4y62qDCCA0qFPLT0EBw69b1qlQzDV3x_AuVcMn8gocbIFLywx2RZDZ4DI7DA5hiJb_-8--cqhdD1h8tqtaTyM6jvkdo8i6awb_V1yI7T3yM1lf09-n1zMuww6aKbGuf3GuAM1IwknXTX051AXl6432A8VRGNdHAo4lgIupJh2jqKns_rTnOJ55ykILb98YJ_ndU199xJ4ilW4wzbQhWnpeiwJ9oCc1e-_vluwvuACcyKVO2Yb5bmRJkuLRjiVpcpVXKXc5Xhd2shCeWR4C_gvZJY2mQX0UeXgMhtEIaDch-SoXbXhMaHey9w2pvKpk9yo0nDJrSts6cGhBdskJBvWX7uejRyLYvzQMSpRQnc606AzHXWmDwl5PfZZd1wcf5V-i2odJZFHOz4A69K9del_WVdCXqFRaNztMDxn-o8WYJLIm6VnoiwAs1WpTMjxRBJ2qZs2D2aley-x1QA_80iQJhLyYmzGnpj51obVHmQ4EuRnQsBPPOqscJxSUYgCoAf0lhP7nMx52tJ-_xY5xOG1CsBoQt4MlvxrWH9e0yf_Y02fklt53Ik5y8tjcrTb7MMzQHY7-zxu4ksddkeE priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3JjtQwELVgkBAXxE5gQEZC4gDWZHFs54QamqhB9AghRuqb5SUBJEiaXg79Afw3Vc4yZBBzjctJnCpXPduVV4Q8F7DiUtJzJsA4GBcVZ4URjqXKOKRjr2Q4MV2eisUZ_7DKV_2G27ZPqxx8YnDUvnW4R34CoToNZFLi9foXw6pReLral9C4Sq4F6jKwZ7kaF1wJRL9s-FFGiZMt-GKJKbe4gAagzA6TYBQ4-__1zH-FpotpkxfOTkNIKm-Rmz2WpLNO-bfJlaq5Q64v-9Pyu-T3vMujg2ZqnNtvjDtQM1Jx0ramP4fquHS9wX6oJhqq41BAsxTQIcXkcxQ9nZUf5xSjnqcgtPz8nn2alyX13UPgKtbirrYVXZiGrsfCYPfIWfnuy9sF68suMCdiuWO2Vp4baZI4q4VTSaxcwVXMXYqHprXMlEeetwr3IpO4TixgkCIFx1kjFgEV3ydHTdtUDwn1Xqa2NoWPneRG5YZLbl1mcw9urbJ1RJLh-2vXc5JjaYwfOqxNlNCdzjToTAed6UNEXo591h0jx6XSb1CtoySyaYcL7ear7ienTqzzuVKFNd5yqwoDKDN3GLdzDwtQF5EXaBQa5zy8njP9rwswSGTP0jORZ4DcilhG5HgiCXPVTZsHs9K9r9jqc8uOyLOxGXti_ltTtXuQ4UiTnwgBt3jQWeE4pCwTGQAQ6C0n9jkZ87Sl-f4tMInDYxVA0oi8Giz5_LX-_00fXT6Kx-RGGuZYytL8mBztNvvqCSC3nX0apucf-NE-6A priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bq9QwEA56BPFFvFs9SgTBBw32kibp43rWsop7EPHAeQu5FQXtLnt52B_g_3YmvXh6vICvzUzbdCaZL53kG0KeC1hxKek5E-AcjIvAWWWEY7kyDunYg4wZ0-WpWJzx9-fleU-Tg2dhLubvMyVeb2H-lLhNFhe9AG7Z4Sq5VmaFiIlZcTJmDCDSFcOhmD_qTQJP5Of_fRa-EIYub5G8lCeN4ae-RW72uJHOOkPfJldCe4dcX_aZ8bvkx7zbMwfN1Di33xh3oGak3aSrhn4fKuHS9Qb10CQ0VsKhgFwpIEGKG81R9HRWf5hTjHCegtDy0zv2cV7X1HcPgatYdztsA12Ylq7HImD3yFn99vPJgvUlFpgTqdwx2yjPjTRZWjTCqSxVruIq5S7HBGkjC-WR0y3gf8csbTILeKPKYZJsEHeAOe-To3bVhoeEei9z25jKp05yo0rDJbeusKWHKSzYJiHZ8P216_nHsQzGNx3XIUrozmYabKajzfQhIS9HnXXHvvFP6Tdo1lESmbPjBXAo3Q9EnVnnS6Uqa7zlVlUGEGXpMEaXHhabLiEv0Ck0jm94PWf6YwrQSWTK0jNRFoDSqlQm5HgiCePSTZsHt9L9vLDVADjzSIkmEvJsbEZN3OvWhtUeZDhS4mdCwC0edF44dqkAxwewAdpy4p-TPk9b2q9fIms4PFYB_EzIq8GTf73W37_po_8Tf0xu5HHM5Swvj8nRbrMPTwC17ezTOFx_AmUCOGA priority: 102 providerName: Springer Nature |
Title | Diagnostic accuracy assessment of molecular prediction model for the risk of NAFLD based on MRI-PDFF diagnosed Chinese Han population |
URI | https://link.springer.com/article/10.1186/s12876-021-01675-y https://www.ncbi.nlm.nih.gov/pubmed/33632126 https://www.proquest.com/docview/2502790516 https://www.proquest.com/docview/2494301667 https://pubmed.ncbi.nlm.nih.gov/PMC7908643 https://doaj.org/article/1bcd5889badb4b89a3245c84715d140c |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Zj9MwELb2kBAviHsDS2UkJB4gkMOxnQeEemxVEK1WFZUqXizHTgBpaUsPif4A_jczzrFkWRAvkRKPk9gz4_kmnswQ8oyDxyWFZT4H4fAZz5mfam78SGqD6dhz4XZMxxM-mrH382R-QOpyR9UEbq517bCe1Gx98erH9_1bUPg3TuElf72BNVZgKC06xgCA_f0hOQbLxNEZG7PLXQWwhi7gHhZkH6D3vP6J5tp7tAyVy-f_56r9m9m6GlJ5ZV_VmavhbXKrwpm0WwrGHXKQL-6SG-NqJ_0e-TkoY-ygmWpjdmtt9lQ3aTrpsqDf6sq5dLXGfshC6irnUEC6FJAjxcB0JJ10hx8GFC2ipUA0nr7zzwfDIbXlQ-Aq1unONzkd6QVdNUXD7pPZ8Oxjf-RXJRl8wwOx9bNCWqaFDoO44EaGgTQpkwEzEW6oFiKWFnPA5fidMgyKMAN8kkawqBaIU4D9D8jRYrnITwi1VkRZoVMbGMG0TDQTLDNxllhY8vKs8EhYz78yVb5yLJtxoZzfIrkqeaaAZ8rxTO098qLpsyqzdfyTuodsbSgx07a7sFx_VpXiqjAzNpEyzbTNWCZTDQg0MWjTEwvOqfHIcxQKhRIKr2d09VsDDBIza6kuT2JAdWkgPHLaogQ9Nu3mWqxUrQYKAGrkUqhxjzxtmrEnxsYt8uUOaBim0A85h1s8LKWwGVIc8xjACfQWLflsjbndsvj6xWUZh8dKgKseeVlL8uVr_X1OH_33dDwmNyOnbpEfJafkaLve5U8A4G2zDjkUc9Ehx72zyfkUzvq833EfSzpOn-E47X36BTehTeo |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVgIuiDeBAkYCcQCreTi2c0Boy3a1S7urqmql3oxjJ4AE2WUfQvsD-Dv8RmbyKimit17jcRJnxvPIjL8h5KWAiEtJx5kA4WBcZJwlRlgWKmMRjj2TZcZ0MhWjU_7xLD7bIr-bszBYVtnoxFJRu5nFf-S7YKrDEkxKvJ__YNg1CrOrTQuNSiwOss1PCNmW78YD4O-rMBzun3wYsbqrALPClyuW5spxI03gR7mwKvCVTbjyuQ0xJ5jLSDmEMcvwV1vg50EKJjYJQS_kaGphBXDfa2Sb44nWHtne258eHbd5C7C3UXM0R4ndJWh_iUW-GLKDa842HfNXdgn41xb8ZQwvFmpeyNaWRnB4m9yqvVfar8TtDtnKirvk-qTOz98jvwZV5R4MU2PtemHshpoW_JPOcvq96cdL5wuch4JBy348FPxnCv4oxXJ3JJ32h4cDinbWUSCaHI_Z0WA4pK56CFzF7t_ZMqMjU9B524rsPjm9EpY8IL1iVmSPCHVOhmluEudbyY2KDZc8tVEaO1CkWZp7JGi-v7Y1Cjo24_imy2hICV3xTAPPdMkzvfHIm3bOvMIAuZR6D9naUiJ-d3lhtvisa3Wgg9S6WKkkNS7lqUoM-LWxRU8hdhDyWo-8RqHQqGXg9aypD0vAIhGvS_dFHIGvmPjSIzsdStAOtjvciJWutdNSn-8lj7xoh3EmVtwV2WwNNByB-QMh4BYPKylslxRFIgKXB2bLjnx21twdKb5-KbHL4bEKnGCPvG0k-fy1_v9NH1--iufkxuhkcqgPx9ODJ-RmWO63kIXxDumtFuvsKfiNq_RZvVkp-XTV-uEP9o16Tw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZbxMxELagSBUvFTcLBYyExAOsuofX9j6GhiiFJkKISn2zfG1Bopsox0N-AP-bGe9BtxwSr-tx9pgZz-fM-BtCXnHYcUnhWMzBOGLGPYtLzW2cSW2Rjt2LkDGdzfn0jH04L86vnOIP1e5dSrI504AsTfXmaOmqxsUlP1rDqiqweBa3wgB5491Ncoth6MN0LT_u8wgQ__LuqMwf5w3CUWDt_31tvhKcrhdOXsuehqA0uUMOWjRJR43675Ibvr5H9mdtvvw--TFuKulgmGprtyttd1T3ZJx0UdHLrj8uXa5wHiqKhv44FPAsBXxIsfwcReejyemYYtxzFIRmn0_iT-PJhLrmJnAVu3H7tadTXdNl3xrsATmbvP9yPI3bxgux5YnYxKaSjmmh0ySvuJVpIm3JZMJshmnTSuTSIdObx38j06RKDaCQMoOls0I0Akp-SPbqRe0fE-qcyEylS5dYwbQsNBPM2NwUDhY2b6qIpN33V7ZlJcfmGN9V2J1IrhqdKdCZCjpTu4i86ecsG06Of0q_Q7X2ksinHS4sVheqdU-VGusKKUujnWFGlhpwZmExchcOtqA2Iq_RKBR6PTye1e3hBXhJ5M9SI17kgN3KRETkcCAJ3mqHw51ZqXa1WCuAoVkgSuMRedkP40ysgKv9YgsyDInyU87hJx41Vti_Up7zHCAIzBYD-xy883Ck_vY1cInDbSWA0oi87Sz512P9_Zs--T_xF2QfzFGdnsw_PiW3s-B-WZwVh2Rvs9r6ZwDrNuZ58Nyfb0ZDlA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnostic+accuracy+assessment+of+molecular+prediction+model+for+the+risk+of+NAFLD+based+on+MRI-PDFF+diagnosed+Chinese+Han+population&rft.jtitle=BMC+gastroenterology&rft.au=Zhang%2C+Qing&rft.au=Zhu%2C+Yueli&rft.au=Yu%2C+Wanjiang&rft.au=Xu%2C+Zhipeng&rft.date=2021-02-25&rft.pub=BioMed+Central+Ltd&rft.issn=1471-230X&rft.eissn=1471-230X&rft.volume=21&rft.issue=1&rft_id=info:doi/10.1186%2Fs12876-021-01675-y&rft.externalDocID=A653663907 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-230X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-230X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-230X&client=summon |